Please enable JS

Blue Companion

BLUE COMPANION provides digital services for health through private-public partnership projects. They also offer CRO services by designing and conducting clinical studies, as well as providing project management and study management services. Their privileged therapeutic domains are neurodegenerative and neuromuscular diseases, as well as ophthalmology.

 

BLUECompanion also designs, deploys and manages customised integrated ICT platforms to treat and monitor on quasi real time different data sources (auto-evaluation questionnaires, wearable devices, robotic interfaces, mobile phones…).

 

Learn more: www.bluecompanion.eu

A LEADING POSITION AND
AN INTERNATIONAL DEPLOYMENT

64 +

countries
involved

20 000 +

investigational
Centres

2 million +

patients
in database

50 000 +

users
worlwide

telemedicine technologies earth

LATEST NEWSOUR NEWS >

telemedecine technologies news

Telemedicine Technologies will be present at SantEXPO Paris – E41

May 22, 2023

Wednesday may 24 TELEMEDICINE TECHNOLOGIES will be present at SantExpo on the OVHcloud stand as a partner of the “Open Trusted Cloud” program. Our president Yoani Matsakis will be representing Telemedicine Technologies, and wil intervene next to Mathieu Godart, CTO and co-founder of SÊMEIA and Emmanuel MEYRIEUX, Client Security manager at OVHcloud. Throughout the day you […]

READ MORE
telemedecine technologies news

Pfizer’s maternal RSV vaccine appears to win over FDA ahead of advisory meeting

May 22, 2023

Fierce Biotech The FDA seems to be satisfied that Pfizer’s RSV vaccine is safe and effective for administration in pregnant women to protect infants from severe disease. The agency’s confidence was revealed in briefing documents filed ahead of an advisory committee meeting set for Thursday. The Vaccines and Related Biological Products Advisory Committee will consider […]

READ MORE
telemedecine technologies news

WHO Announces End to COVID-19 Public Health Emergency of International Concern—At least Provisionally

May 22, 2023

Trial Site News The World Health Organisation (WHO) decided Thursday May 4, 2023, to end the COVID-19 public health emergency of international concern (PHEIC). TrialSite cautions that this is a provisional (temporary) status while WHO considers its forward-looking options (2023-2025). Importantly, in “The COVID-19 Emergency is Over, Sort of,” TrialSite reports that in America some […]

READ MORE